| Response to the novel corona virus (COVID-19) pandemic across Africa: successes, challenges, and implications for the future OO Ogunleye, D Basu, D Mueller, J Sneddon, RA Seaton, ... Frontiers in pharmacology 11, 1205, 2020 | 213 | 2020 |
| Strategies to improve antimicrobial utilization with a special focus on developing countries B Godman, A Egwuenu, M Haque, OO Malande, N Schellack, S Kumar, ... Life 11 (6), 528, 2021 | 174 | 2021 |
| Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries … B Godman, M Haque, J McKimm, M Abu Bakar, J Sneddon, J Wale, ... Current medical research and opinion 36 (2), 301-327, 2020 | 159 | 2020 |
| Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future B Godman, D Basu, Y Pillay, JC Mwita, GM Rwegerera, ... Frontiers in pharmacology 11, 108, 2020 | 124 | 2020 |
| Assessing adherence to antihypertensive therapy in primary health care in Namibia: findings and implications MM Nashilongo, B Singu, F Kalemeera, M Mubita, E Naikaku, A Baker, ... Cardiovascular drugs and therapy 31, 565-578, 2017 | 102 | 2017 |
| Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications S Nakwatumbah, D Kibuule, B Godman, V Haakuria, F Kalemeera, ... Expert review of anti-infective therapy 15 (7), 713-721, 2017 | 89 | 2017 |
| Fixed dose drug combinations–are they pharmacoeconomically sound? Findings and implications especially for lower-and middle-income countries B Godman, H McCabe, T D Leong, D Mueller, AP Martin, I Hoxha, ... Expert review of pharmacoeconomics & outcomes research 20 (1), 1-26, 2020 | 88 | 2020 |
| Validity of World Health Organisation prescribing indicators in Namibia’s primary healthcare: findings and implications Q Niaz, B Godman, A Massele, S Campbell, A Kurdi, HR Kagoya, ... International journal for quality in health care 31 (5), 338-345, 2019 | 88 | 2019 |
| Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring RK Verbeeck, G Günther, D Kibuule, C Hunter, TW Rennie European journal of clinical pharmacology 72, 905-916, 2016 | 80 | 2016 |
| Impact of COVID-19 pandemic on pharmaceutical systems and supply chain–a phenomenological study T Tirivangani, B Alpo, D Kibuule, J Gaeseb, BA Adenuga Exploratory Research in clinical and social pharmacy 2, 100037, 2021 | 79 | 2021 |
| Rapid assessment of the potential paucity and price increases for suggested medicines and protection equipment for COVID-19 across developing countries with a particular focus … IA Sefah, OO Ogunleye, DO Essah, SA Opanga, N Butt, A Wamaitha, ... Frontiers in pharmacology 11, 588106, 2021 | 74 | 2021 |
| Antibiotic use in acute respiratory infections in under-fives in Uganda: findings and implications D Kibuule, HR Kagoya, B Godman Expert review of anti-infective therapy 14 (9), 863-872, 2016 | 73 | 2016 |
| Awareness of, responsiveness to and practice of patients' rights at Uganda's national referral hospital HR Kagoya, E Ekirapa-Kiracho, JC Ssempebwa, D Kibuule, ... African journal of primary health care and family medicine 5 (1), 1-7, 2013 | 71 | 2013 |
| Tackling antimicrobial resistance across sub-Saharan Africa: Current challenges and implications for the future B Godman, A Egwuenu, E Wesangula, N Schellack, AC Kalungia, ... Expert Opinion on Drug Safety 21 (8), 1089-1111, 2022 | 63 | 2022 |
| Compliance to prescribing guidelines among public health care facilities in Namibia; findings and implications Q Niaz, B Godman, S Campbell, D Kibuule International journal of clinical pharmacy 42 (4), 1227-1236, 2020 | 63 | 2020 |
| Challenges and innovations brought about by the COVID-19 pandemic regarding medical and pharmacy education especially in Africa and implications for the future A Etando, AA Amu, M Haque, N Schellack, A Kurdi, AA Alrasheedy, ... Healthcare 9 (12), 1722, 2021 | 53 | 2021 |
| Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future B Godman, D Basu, Y Pillay, PHRF Almeida, JC Mwita, GM Rwegerera, ... Hospital practice 48 (2), 51-67, 2020 | 53 | 2020 |
| Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income … B Godman, C Grobler, M Van-De-Lisle, J Wale, WB Barbosa, A Massele, ... Expert opinion on pharmacotherapy 20 (18), 2237-2255, 2019 | 50 | 2019 |
| Evidence-based public policy making for medicines across countries: findings and implications for the future B Godman, J Fadare, HY Kwon, CZ Dias, A Kurdi, IP Dias Godoi, ... Journal of comparative effectiveness research 10 (12), 1019-1052, 2021 | 47 | 2021 |
| Assessment of multidrug-resistant tuberculosis (MDR-TB) treatment outcomes in Sudan; findings and implications MH Ali, AA Alrasheedy, D Kibuule, B Godman, MA Hassali, HMH Ali Expert review of anti-infective therapy 17 (11), 927-937, 2019 | 47 | 2019 |
